000 | 01071 a2200313 4500 | ||
---|---|---|---|
005 | 20250514020928.0 | ||
264 | 0 | _c20020114 | |
008 | 200201s 0 0 eng d | ||
022 | _a0098-7484 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiller, F G | |
245 | 0 | 0 |
_aSalmeterol and inhaled corticosteroids in patients with persistent asthma. _h[electronic resource] |
260 |
_bJAMA _cDec 2001 |
||
300 |
_a3075-6; author reply 3077-8 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xtherapeutic use |
650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aSalmeterol Xinafoate |
650 | 0 | 4 | _aSteroids |
700 | 1 | _aShorr, A F | |
773 | 0 |
_tJAMA _gvol. 286 _gno. 24 _gp. 3075-6; author reply 3077-8 |
|
999 |
_c11667070 _d11667070 |